Skip to main content
Signal8

Schaffert Susanne

SEC insider (Form 3/4/5 filer). CIK 0001938363. Director at BioNTech SE (BNTX) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2025. Located in MAINZ.

Companies Schaffert Susanne has filed insider reports for

  • BioNTech SE (BNTX): Director
  • INCYTE CORP (INCY): Director
Schaffert Susanne profile photo

Schaffert Susanne

CIK: 0001938363

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BioNTech SE logo
BNTX

BioNTech SE

Director
INCYTE CORP logo
INCY

INCYTE CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jun 10, 2025
    Tax Payment
    Direct
    849 shares at avg. $70.07$59K
  • INCYTE CORP logo
    INCY

    INCYTE CORP

    Jun 10, 2025
    Award
    Direct
    2.5K shares-

1-2 of 2